Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 104.1721.125.79-22.6416.51

What is the latest Core EBITDA Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of GLENMARK PHARMACEUTICALS is 104.17 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026104.17
Mar202521.12
Mar20245.79
Mar2023-22.64
Mar202216.51

How is Core EBITDA Growth of GLENMARK PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 104.17
393.23
Mar2025 21.12
264.77
Mar2024 5.79
Positive
Mar2023 -22.64
Negative
Mar2022 16.51 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹65,837.3 Cr 9.6% -0.1% 24.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,991.0 Cr 1.1% -4.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹256,310.0 Cr 7.5% 1.3% 45.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,604.0 Cr 1.8% -6.3% 26.1% Stock Analytics
DR REDDYS LABORATORIES ₹111,722.0 Cr 9.3% 9.5% 4.3% Stock Analytics
CIPLA ₹109,628.0 Cr 1.5% -2.3% -17.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

9.6%

-0.1%

24.4%

SENSEX

1.2%

0.4%

-12.2%


You may also like the below Video Courses